| For: | Bhat S, Fernandez CJ, Lakshmi V, Pappachan JM. Efficacy and safety of incretin co-agonists: Transformative advances in cardiometabolic healthcare. World J Cardiol 2025; 17(8): 107991 [PMID: 40949933 DOI: 10.4330/wjc.v17.i8.107991] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v17/i8/107991.htm |
| Number | Citing Articles |
| 1 |
Yange Meng, Ting Jin, Luping Ren, Michelle L. Thompson, Yue Wang. Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta-Analysis. Journal of Clinical Question 2025; 2(6) doi: 10.69854/jcq.2025.0033
|
| 2 |
Anish Preshy, Cornelius J. Fernandez, Mohammad Hamid Nedai, Joseph M. Pappachan. Anti‐Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea. Chronic Diseases and Translational Medicine 2026; 12(2) doi: 10.1002/cdt3.70040
|
| 3 |
Joachim Neumann, Milena Jarikova, Uwe Kirchhefer, Britt Hofmann, Ulrich Gergs. Contractile effects of albiglutide in the human and mouse atrium. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1831742
|
| 4 |
Roxana-Cristina Dobriceanu, Ianis Kevyn Stefan Boboc, Liliana Mititelu Tartau, Andreea Daniela Meca, Carmen Nicoleta Oancea, Maria-Alexandra Paceana, Marius-Mihai Pastiu, Adina Turcu-Stiolica, Maria Bogdan. Differential Anti-Inflammatory Effects of Semaglutide and Tirzepatide in Experimental Diabetes Mellitus. Current Issues in Molecular Biology 2026; 48(7) doi: 10.3390/cimb48070675
|
| 5 |
Urna Kansakar, Stanislovas S. Jankauskas, Shivangi Pande, Pasquale Mone, Fahimeh Varzideh, Gaetano Santulli. Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 Diabetes. International Journal of Molecular Sciences 2026; 27(3) doi: 10.3390/ijms27031409
|
| 6 |
Adir Alper, Gal Peleg, Adina Fagin, Priyansh Shah, Ishmum Chowdhury, Antony Gonzales, Robert Faillace. Efficacy and safety of orforglipron, an oral small-molecule GLP-1 receptor agonist, on cardiometabolic outcomes: a meta-analysis and systematic review. Cardiovascular Diabetology – Endocrinology Reports 2026; 12(1) doi: 10.1186/s40842-025-00270-4
|